Search in:

Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue

Submit an article Journal homepage

Open access

257

Views

CrossRef citations to date

Altmetric

Review

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

Paweł Kawalec1 Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland, [email protected]Correspondence[email protected]

Katarzyna Śladowska2 Department of Experimental Hematology, Institute of Zoology and Biomedical Research, Faculty of Biology and Earth Sciences, Jagiellonian University, Kraków, Poland

Iwona Malinowska-Lipień3 Department of Internal and Community Nursing, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland

Tomasz Brzostek3 Department of Internal and Community Nursing, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland

Maria Kózka4 Department of Clinical Nursing, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland

Pages 275-284 | Published online: 13 Feb 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (15)

Luana Heimfarth, Marília Matos Rezende, Erik Willyame Menezes Pereira, Fabiolla Rocha Santos Passos, Brenda Souza Monteiro, Tiffany Karoline Barroso Santos, Natália Teles Lima, Isana Carla Leal Souza, Ricardo Luiz Cavalcanti de Albuquerque Junior, Pollyana de Souza Siqueira Lima, Adriano Antunes de Souza Araújo, Lucindo José Quintans Júnior, Bonglee Kim, Henrique D.M. Coutinho & Jullyana de Souza Siqueira Quintans. (2022) Pharmacological effects of a complex α-bisabolol/β-cyclodextrin in a mice arthritis model with involvement of IL-1β, IL-6 and MAPK. Biomedicine & Pharmacotherapy 151, pages 113142.
Crossref

Suchitra Nishal, Vikas Jhawat, Parmita Phaugat & Rohit Dutt. (2022) Rheumatoid Arthritis and JAK-STAT Inhibitors: Prospects of Topical Delivery. Current Drug Therapy 17:2, pages 86-95.
Crossref

Jiamin Zhang, Chao Xu, Liang Gao, Dongmei Zhang, Chen Li & Jingbo Liu. (2021) Influence of anti‐rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta‐analysis. Journal of Periodontal Research 56:6, pages 1099-1115.
Crossref

Michela Sperti, Marta Malavolta, Gloria Ciniero, Simone Borrelli, Marco Cavaglià, Stefano Muscat, Jack Adam Tuszynski, Antonella Afeltra, Domenico Paolo Emanuele Margiotta & Luca Navarini. (2021) JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies. Journal of Molecular Graphics and Modelling 104, pages 107789.
Crossref

Zahra Bahari, Zohreh Jangravi, Hassan Ghoshooni, Mohammad Reza Afarinesh & Gholam Hossein Meftahi. (2021) Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection. Inflammation Research 70:4, pages 389-405.
Crossref

Codrina Ancuța, Cristina Pomîrleanu, Claudia Mihailov, Rodica Chirieac, Eugen Ancuța, Cristina Iordache, Codruța Bran & Oana Tanculescu. (2021) Efficacité du baricitinib sur l’inflammation parodontale chez les patients atteints de polyarthrite rhumatoïde. Revue du Rhumatisme 88:2, pages 120-124.
Crossref

Codrina Ancuța, Rodica Chirieac, Eugen Ancuța, Oana Țănculescu, Sorina Mihaela Solomon, Ana Maria Fătu, Adrian Doloca & Cristina Iordache. (2021) Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease. Journal of Clinical Medicine 10:4, pages 878.
Crossref

Qichao Bao, Liangying Zhang, Nan Wang, Brian Gabet, Weikang Yang, Xingyang Gao, Qidong You & Zhengyu Jiang. (2020) Hydrogen Peroxide Inducible JAK3 Covalent Inhibitor: Prodrug for the Treatment of RA with Enhanced Safety Profile. ACS Medicinal Chemistry Letters 11:11, pages 2182-2189.
Crossref

Xia Zhao, Xiao Yan Sheng, Christopher D. Payne, Xin Zhang, Feng Wang & Yi Min Cui. (2020) Pharmacokinetics, Safety, and Tolerability of Single‐ and Multiple‐Dose Once‐Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo‐Controlled Study. Clinical Pharmacology in Drug Development 9:8, pages 952-960.
Crossref

Lucindo J. Quintans-Júnior, Sathiyabama R. Gandhi, Fabiolla R.Santos Passos, Luana Heimfarth, Erik W.Menezes Pereira, Brenda S. Monteiro, Katielen Silvana dos Santos, Marcelo Cavalcante Duarte, Lucas Silva Abreu, Yuri M. Nascimento, Josean F. Tavares, Marcelo S. Silva, Irwin R.A. Menezes, Henrique D.M. Coutinho, Ádley A.N. Lima, Gokhan Zengin & Jullyana S.S. Quintans. (2020) Dereplication and quantification of the ethanol extract of Miconia albicans (Melastomaceae) by HPLC-DAD-ESI-/MS/MS, and assessment of its anti-hyperalgesic and anti-inflammatory profiles in a mice arthritis-like model: Evidence for involvement of TNF-α, IL-1β and IL-6. Journal of Ethnopharmacology 258, pages 112938.
Crossref

Jacopo Angelini, Rossella Talotta, Rossana Roncato, Giulia Fornasier, Giorgia Barbiero, Lisa Dal Cin, Serena Brancati & Francesco Scaglione. (2020) JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future. Biomolecules 10:7, pages 1002.
Crossref

Faping Wang, Ling Sun, Shaohua Wang, John M. DavisIIIIII, Eric L. Matteson, M. Hassan Murad, Fengming Luo & Robert Vassallo. (2020) Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Mayo Clinic Proceedings 95:7, pages 1404-1419.
Crossref

Codrina Ancuța, Cristina Pomîrleanu, Claudia Mihailov, Rodica Chirieac, Eugen Ancuța, Cristina Iordache, Codruța Bran & Oana Țănculescu. (2020) Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis. Joint Bone Spine 87:3, pages 235-239.
Crossref

Pamela Anjara, Matthew Jiang & Maninder Mundae. (2019) Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib. Clinical Rheumatology 39:2, pages 613-614.
Crossref

Farhad Seif, Hossein Aazami, Majid Khoshmirsafa, Monireh Kamali, Monireh Mohsenzadegan, Majid Pornour & Davood Mansouri. (2020) JAK Inhibition as a New Treatment Strategy for Patients with COVID-19. International Archives of Allergy and Immunology 181:6, pages 467-475.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

Articles from other publishers (15)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

Citations (15)

Articles from other publishers (15)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date